Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This study will determine the concentrations of the antibiotic meropenem when administered as
a 3 hour prolonged infusion in children with cystic fibrosis who are hospitalized with an
acute pulmonary exacerbation. Safety and practicality of administering meropenem as a 3 hour
infusion will be measured.